So far, many pharmaceutical companies want to buy a monkey, which probably costs about150,000, or even asks for150,000, but they may not be able to buy the crab-eating monkey they want. The soaring price of monkeys can also show that the demand for them in China is relatively large now. Monkeys are very important in drug experiments. For example, many pharmaceutical companies are worried that the demand is in short supply after the experiments, so they directly buy biological companies as their wholly-owned subsidiaries, so that there can be enough experimental monkeys.
The leading pharmaceutical companies in these markets are not able to imitate the behavior of buying biological companies, and leading companies like this have to worry that they can't buy experimental monkeys, so we can imagine how difficult it is for other pharmaceutical companies to buy an experimental monkey. After the experimental monkeys enter the laboratory, they are equivalent to disposable articles, because after the drugs are tested on them, it is impossible to use them in other experiments. Therefore, sufficient experiments are needed in the process of drug research and development, and then the smooth output of drugs can be guaranteed.
However, at present, there are relatively few domestic manufacturers of experimental monkeys, and in recent years, it is forbidden to import from abroad. Therefore, if we want to meet domestic demand, increasing supply is the most important thing. The current problem lies in the huge demand gap in domestic supply, which leads to soaring prices.